You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chromosome

Showing 1 - 25 of 1,591
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Structural Chromosome Rearrangements and Brain Disorders

Enrolling by invitation
  • Rare Diseases
  • +2 more
    • Stockholm, Sweden
      Anna Lindstrand
    Oct 2, 2023

    Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

    Recruiting
    • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Dec 13, 2022

    Endocrine, Metabolic, Cardiovascular and Immunological Aspects

    Recruiting
    • Sex Chromosome Abnormality
    • +5 more
    • No intervention other than obtaining biopsies
    • Aarhus, Region Midt, Denmark
      Aarhus university hospital
    Jun 20, 2022

    Fetal Membrane Thickness and Fetal Chromosomal Aneuploidies

    Recruiting
    • Chromosome Aberrations
    • Ultrasound screening
    • Tianjin, Tianjin, China
      Tianjin Central Hospital of Obstetrics and Gynecology
    Nov 15, 2023

    Chromosome 18 Clinical Research Center

    Recruiting
    • Chromosome Aberrations
    • +2 more
    • Determination of growth hormone status
    • +12 more
    • San Antonio, Texas
    • +1 more
    Nov 1, 2022

    Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Positive Trial in New York (Blinatumomab, dasatinib, dexamethasone)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Philadelphia Chromosome-Positive
    • Blinatumomab
    • +3 more
    • New York, New York
    • +1 more
    Nov 10, 2022

    Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Nov 28, 2022

    Acute Lymphoblastic Leukemia (ALL) Trial (Nilotinib)

    No longer available
    • Acute Lymphoblastic Leukemia (ALL)
    • (no location specified)
    Aug 5, 2022

    MDS, Myelodysplastic Anemia, Myelodysplastic Syndrome With Isolated Del(5Q) Trial (description of MDS pzatient cohort)

    Recruiting
    • Myelodysplastic Syndromes
    • +5 more
    • description of MDS pzatient cohort
    • Brest, France
      Chu Brest
    Oct 27, 2022

    Invasive PGT-A Embryo Selection Versus Non Invasive PGT-A

    Recruiting
    • Infertility
    • +2 more
    • embryo selection
    • Thessaloníki, Thessaloniki, Greece
      Assisting Nature
    Sep 16, 2022

    Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

    Not yet recruiting
    • Hematologic Malignancy
    • +21 more
    • (no location specified)
    Feb 9, 2023

    Time Lapse Assisted Embryo Selection Versus Non Invasive PGT-A

    Recruiting
    • Infertility
    • +2 more
    • embryo selection
    • Thessaloníki, Greece
      Assisting Nature
    Sep 26, 2022

    Acute,Leukemia, Lymphoid Trial in Tianjin (Dasatinib, prednisone, cyclophosphamide)

    Completed
    • Acute,Leukemia, Lymphoid
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Aug 2, 2022

    Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

    Recruiting
    • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
    • Frankfurt, Germany
      Department of Medicine, Hematology and Oncology, Goethe Universi
    Sep 24, 2023

    Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Tianjin (Olverembatinib, Venetoclax, prednisone)

    Recruiting
    • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Oct 21, 2022

    Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

    Not yet recruiting
    • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
    • (no location specified)
    Jul 11, 2022

    Chromosome Anomalies in Early Pregnancy Loss

    Enrolling by invitation
    • Early Pregnancy Loss
    • cfDNA analysis
    • San Juan Capistrano, California
      Quest Diagnostics
    Feb 24, 2022

    Assignment for Whole Chromosome Using SNP-based NIPT in

    Recruiting
    • Vanishing Twin
    • +3 more
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Sep 27, 2022

      Acute Lymphoblastic Leukemia Trial in New York (Ruxolitinib, Dasatinib, Dexamethasone)

      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jul 25, 2022

      Myeloproliferative Tumor, Optical Genome Mapping, Cytogenetics Trial in Amiens (Blood sample)

      Recruiting
      • Myeloproliferative Neoplasm
      • +4 more
      • Blood sample
      • Amiens, Picardie, France
        Centre Hospitalier Universitaire d'Amiens
      Jan 27, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

      Recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 31, 2022

      Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 11, 2022

      Chromosome 9 P Minus Syndrome

      Recruiting
      • Chromosome 9P Deletion Syndrome
      • +4 more
        • Saint Louis, Missouri
          Washington University School of Medicine
        Nov 30, 2021

        Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
        • Houston, Texas
          M D Anderson Cancer Center
        Jun 24, 2022

        Philadelphia-Positive ALL Trial in Suzhou (Olverembatinib)

        Not yet recruiting
        • Philadelphia-Positive ALL
        • Suzhou, Jiangsu, China
          First Affiliated Hospital of Soochow University
        Jul 1, 2023